FTSE 250 movers: Oxford Nanopore surges on sales beat

12th Jan 2026 13:10

(Sharecast News) - FTSE 250 (MCX) 22,996.82 -0.17%

Precious metals miner Hochschild shone as gold and silver prices rose after developments in Iran and news of a Department of Justice investigation into Federal Reserve chair Jerome Powell.

Harbour Energy gushed higher after an upgrade to 'buy' at SB1 Markets.

Shares in Oxford Nanopore Technologies surged after the FTSE 250 firm said full-year sales had beaten guidance in 2025.

Updating on year-end trading, the business - a specialist in nanopore-based molecular sensing technology - said revenues were set to come in between £223m and £224m.

That represents a 22% increase on 2024, or a 24% jump on a constant currency basis.

Oxford Nanopore had previously steered for an increase of between 20% and 23% on a constant currency basis.

It also flagged "continued progress" during the year on its path to profitability.

As at 0830 the stock had jumped 8% at 151.6p.

Driving the "strong" 2025 performance was a 60% surge in clinical revenues. All segments saw revenue growth, however, including biopharma - up 30% - and applied industrial, which reported a 27% spike in sales.

The business also confirmed it had ended the year with around £302m in cash, cash equivalents and other liquid investments, ahead of expectations, following improved working capital.

Oxford Nanopore said the higher-than-expected cash provided "continued balance sheet strength to support execution of the group strategy".

Oxford Nanopore, which was founded in 2005 as a spin out from the Oxford University, is due to publish results for the year to 31 December on 2 March.